chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Feet are swollen; bottom of his feet are burning; round red marks on his leg and his knee cap (right leg)/ looks like a round mark like he hit something; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Feet are swollen), BURNING SENSATION (bottom of his feet are burning) and ERYTHEMA (round red marks on his leg and his knee cap (right leg)/ looks like a round mark like he hit something) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044321A and 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included AMLODIPINE for Hypertension.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Feet are swollen), BURNING SENSATION (bottom of his feet are burning) and ERYTHEMA (round red marks on his leg and his knee cap (right leg)/ looks like a round mark like he hit something). At the time of the report, PERIPHERAL SWELLING (Feet are swollen), BURNING SENSATION (bottom of his feet are burning) and ERYTHEMA (round red marks on his leg and his knee cap (right leg)/ looks like a round mark like he hit something) had not resolved.            No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-122291 (Linked Report).
Feeling internal vibration throughout core, lasting approx 5-7 days. Recurring symptoms 2 weeks after second dose 04/09/2021, again lasting 5-7 days. Recurrence of vibrations 05/21/2021 and 06/25/2021  each time lasting approx 5-7 days in duration.  Most recent  recurrence 09/06/2021 has vibration feeling  into arms and legs and has persisted since.
On Wednesday, 3/2/11, pt started having severe abdominal pain. She then started with diarrhea, no vomiting or nausea. As of 3/7/11, pt's symptoms have resolved.
lightheaded and  dizzy; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 09Feb2021 13:20 (Batch/Lot number was not reported) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included PFIZER BIONTECH COVID 19 VACCINE, first dose on an unspecified date for COVID-19 immunization. The patient experienced lightheaded and dizzy on an unspecified date with outcome of unknown.    Information on the lot/batch number has been requested.
This case was reported by a physician and described the occurrence of rash in a 2-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included PEDIARIX; GlaxoSmithKline; unknown; unknown given on 10 September 2010; ENGERIX B; GlaxoSmithKline; unknown; unknown given on 10 September 2010; PREVNAR; non-gsk manufacturer; unknown; unknown given on 10 September 2010. On 10 September 2010 the subject received unspecified dose of ROTARIX (unknown). On 22 September 2010, 12 days after vaccination with ROTARIX, the subject experienced rash. The 2-month old subject received ROTARIX and presented 12 days later with rashes on torso and extremities. On an unspecified date in September 2010, the event was unresolved.
This case was reported by a physician via call center representative and described the occurrence of fever in a elderly patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever, general body pain and chills. On an unknown date, the outcome of the fever, general body pain and chills were recovered/resolved. It was unknown if the reporter considered the fever, general body pain and chills to be related to SHINGRIX. Additional details were provided as follows: This case was reported via chat. The age at vaccination was not reported. The patient had a febrile reaction with chills and body aches lasting 2.5 days. The healthcare professional had declined to provide any contact information.
He received the vaccine, had very painful going in and tingling going down his left arm and to the elbow which was numb, and the left little finger was numb, and a dizzy spell afterward which was typical for him.  He then on the 9th day had extreme intercostal pain in the ribs on the right side and his right shoulder extremely painful, low grade fever, chills, fatigue and inability to draw a full breath.  He called the doctor and they were on the way to the clinic they told him to go to the ER based on his symptoms.  He went to the ER and they admitted him and did blood work, and then did a chest x-ray, then a chest CT scan and it was positive for pulmonary embolism.  He was treated with an anti-inflammatory through the IV and a blood thinner to the stomach.  He was hospitalized for 1 full day, and discharged home with Eliquis double dose for 14 days and then a single dose until further notice.    He is still having fatigue and aches on the right side of his brain and aches in his feet, but is to see a pulmonologist for his lungs, as it will take up to 6 months for it to resolve.  He also has damage to the right side of the heart and lung.  Is waiting to get a CT of the brain.
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown date the unspecified number of patients were vaccinated with an improperly stored dose of PROQUAD (Merck) (dose, dose number, route, anatomical location, lot number and expiration date were unspecified). Concomitant therapies were not reported. No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
got big lumps on his neck; began to feel ill; This is a spontaneous report from a contactable consumer (patient's relative). A 77-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: not reported) via an unspecified route of administration, administered in Arm Left on 12Feb2021 as (at the age of 77-years-old) dose 1, single for COVID-19 immunization. Medical history included blood pressure measurement and pain from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  List of any other medications the patient received within 2 weeks of vaccination was blood pressure and pain medication.  No known allergies reported. Prior to vaccination the patient did nod diagnosed with COVID-19. On 16Feb2021 the patient experienced got big lumps on his neck and began to feel ill. On an unspecified date the patient underwent lab tests and procedures which included sars-cov-2 test (no result was reported). No treatment received for the adverse event. The clinical course reported as follows, the reporter stated that four or five days after the first job his father got big lumps on his neck and began to feel ill, he went to the doctor and they weren't too worried about it. The adverse event result in doctor or other healthcare professional office/clinic visits. The outcome of the events was reported as unknown.  No follow-up attempts are needed. No further information expected.
Developed Pnuemonia 3 days after flu shot12/03/09 Medical records and discharge summary received for DOS 10/29/09.  Final DX: Viral pneumonia  Infant w/fever. Cough. WBC increased. CXR abn. Improved w/tx. D/C to home.
CHRONIC PERSISTENT COUGH; DRY NON-PRODUCTIVE LASTING 24 HOURS DAY AND NIGHT WHEEZING AND SHORTNESS OF BREATH
Report A0372406A describes autism in a 6 year old female who received hepatitis B vaccine (brand name unknown). This report was received as part of the litigation proceedings, with forwarding of medical records. The medical history included otitis media, multiple upper respiratory infections, and rhinitis. Developmental history: It was noted that the vaccinee did not roll over at 6 months of age. At 10 months of age she stood while holding on and sat up. At 12 months of age, she stood and walked while holding on. Following the reported onset of autism, the vaccinee experienced upper respiratory infections, viral syndromes, bronchitis, contact dermatitis, sprained finger, eyelid ecchymosis, and foreign body in the ear canal. These events were not reported as adverse events due to vaccine administration, but were found during the course of review of the vaccinee's medical records. Therefore, they are not listed as adverse events. On an unspecified date, 7/28/1999 and 12/09/1999, the vaccinee received her first, second, and third injections of hepatitis B vaccine (brand name unknown), respectively. On 09/28/2000, 11/24/2000, 01/26/1991, 2/14/1992, and 08/26/1994, the vaccinee received her first, second, third, fourth and fifth injections of diphtheria tetanus and pertussis vaccine (brand name unknown), respectively. On 09/28/1990, 11/24/1990, 2/14/1992, and 03/09/1994, the vaccinee received her first, second, third and fourth doses of poliomyelitis virus vaccine (brand name unknown), respectively. On 7/24/1991 and 8/29/1994, the vaccinee received her first and second injections of MMR respectively. On 7/28/199 and 4/27/2000, the vaccinee received her first and second injections of hepatitis A vaccine (brand name unknown), respectively. On 10/11/1999, the vaccinee received her first injection of influenza virus vaccine. The vaccinee's attorney alleged that the vaccinee was injected with multiple childhood vaccinations which unbeknownst to the parents, contained the dangerous and highly toxic mercury based preservative, thimerosal.... As a result of the mercury in the thimerosal-containing vaccinations that the vaccinee received as an infant, the vaccinee now suffers and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning. Autism and hyperactive attention deficit disorder were first documented in 1996, when the vacinee was six years of age. Autism is considered medically serious.
10 minutes after the shot while I was waiting my hand started to feel numb and cold, the feelings moved to the face, mostly nose and left leg. The paresthesia feelings and tingling were on and off for three days and still happening in the left arm.  On the same day I also felt a bit chest tightness more then usual and a weird feeling in the throat
Patient called complained of red blotches and itching. Patient did go to emergency room.  Was treated for unknown allergic reaction with Benadryl and steroids.
This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. On 25-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Pt admitted on 10/19/2021: Admission is r/t trauma. Tested a false positive for COVID during admission. The Physician states this a a false positive d/t error with laboratory.  46 year old female presents to the ER via EMS as a level 1 trauma activation.  Patient presents with Hare traction in place to the right leg.  Patient reports she was standing beside her ATV when her dogs jumped in it and pressed the gas causing the ATV to strike her down and rolled onto her right pelvis/abdomen.  Denies striking her head or loss of consciousness.  C/o right thigh pain.  Full trauma evaluation reveals right femur fracture.  Right PT pulse was found with doppler at bedside.  Orthopedics was consulted and admitted to the trauma services.   10/21/2021: Pt is currently in-patient.
autism like behavior, lack of speech;no socialization, hyperactive, picky eater, ritual acts, banging head on floor & self injury acts;tx discreet trial therapy; tantrums;
Localized redness throughout inner-upper right arm. Warmth with pain in muscle and skin.
PAIN IN ARM AS IF SOMEONE HAD PUNCHED HIM HARD WITH THEIR KNUCKLES. STILL OCCURRING 1 AND A HALF MONTHS LATER. ARM IS STILL SORE ALL THE TIME. RECENTLY STARTING USING A TENS DEVICE THAT HE RECEIVED FOR TENNIS ELBOW IN OTHER ARM.  HE USED IT ON ARM PAIN DUE TO INJECTION AND IT MADE IT FEEL BETTER.
She complained of SOB, heavy chest, shivers, aches.  She said she felt "hot" but did not take her temperature.  She called the doctor's office this a.m.
COVID arm; Big lump on arm; Arm very itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE MASS (Big lump on arm) and VACCINATION SITE PRURITUS (Arm very itchy) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE MASS (Big lump on arm) and VACCINATION SITE PRURITUS (Arm very itchy). At the time of the report, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE MASS (Big lump on arm) and VACCINATION SITE PRURITUS (Arm very itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Sorry for delay in reporting. I didn't realize I should report the adverse effects. I had the vaccine at 11:30 am and felt fine. But around 6pm,  I was sitting outside on a cool night with a jacket and scarf on and I suddenly very very hot and  had to take off my layers. I felt nauseous. I got up to go inside because I thought I would throw up and then fainted.  I came to a second later (some friends where with me) and felt extremely nauseous. My friends brought me a bucket and I got sick. I felt immediately better. But later that night I had a headache, and chills. I didn't get sick again, but I left as if I had the flu.  I felt better in the morning.
Screamed for 7 hrs p/immun were given; @ ER t100.5 R;
Moderna, Dose Number: 4 / Pfizer, Dose Number: 1, 2, 3; COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Apr2021 as dose 1, single (Lot number: EW0170), in left arm, on 15May2021 as dose 2, single (Lot number: EW0182), in left arm and on 16Nov2021 at 16:00 as dose 3 (booster), single (Lot number: FJ1620) at the age of 41 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 13Sep2022 at 09:00 as dose 4 (booster), single (Lot number: AS714OC), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Mood disorders" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Jan2023, outcome "recovered" (09Feb2023) and all described as "COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Moderna, Dose Number: 4 / Pfizer, Dose Number: 1, 2, 3". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Jan2023) positive, notes: COVID 19 Treatment. The patient was treated with Paxlovid from 26Jan202. No follow-up attempts are possible. No further information is expected.
Approx 1 wk later devel large indurated area of approx 5in in diameter & soreness @ inject site in deltoid region; @ time of report pt's exp continued; No further details were provided;
After injection I started to feel scratchiness in the back of my throat and nose.  By the bed time at 10pm I was congested and had an intermittent cough.  The following morning the symptoms were cough, runny nose, sore throat.
I received a booster dose of Pfizer COVID 19 vaccine on 10/20/2021. I had the following adverse effects: 1. Tachycardia, started 1 day after vaccination. 2. Worsening of my chronic neck pain, started 4 days after vaccination. 3. Elevated blood pressure, started 6 days after vaccination. 4. Diarrhea, two episodes within one week of the vaccination.  I did not have these adverse effects after the first two doses of the vaccine.  I took Aleve a few times within the first two weeks to control neck pain. Then, starting two weeks from the vaccination, I started taking Aleve on a regular basis, 220 mg two times a day.  Tachycardia improved several days after onset and went away on week 3. Elevated blood pressure improved several days after onset but I was advised by my doctors that I have chronic hypertension anyway and may need to start blood pressure medications. Neck pain improved on week 3.
This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022). No concomitant product use was reported. Vaccine was stored in refrigerator on 04-Jun-2022. Patient received half dose. Vial did not undergo any temperature excursions. No treatment information was provided.
Headaches after first shot on and off for a couple of days. Started within 30 minutes after first shot.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches after first shot on and off for a couple of days. Started within 30 minutes after first shot.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced HEADACHE (Headaches after first shot on and off for a couple of days. Started within 30 minutes after first shot.). The patient was treated with IBUPROFEN (ADVIL HEADACHE & MIGRAINE) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headaches after first shot on and off for a couple of days. Started within 30 minutes after first shot.) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication include Medication for Thyroid everyday.
now has a fever and is wanted to know if she can take Tylenol; This is a spontaneous report from a Pfizer sponsored program. A non-contactable consumer reported for a female patient A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single dose for covid-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, the patient experienced fever. It was reported that patient received the vaccine yesterday and next day has a fever and wanted to know if she can take Tylenol. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
On 11/13/02, pt. woke up with c/o left arm feeling sore & heavy.  C/o swollen gland in left axilla.  States she fainted at home in the bathroom.  Was seen at Hospital E.D. at 8:15 am, was evaluated and treated with benedryl 50 mg. p.o. Per 60 day follow up: Pt has recovered. 01/20/2003 spoke with pt- finally recovered.
Outbreak of Shingles Physician prescribed 10days of  Gabapentin Valtrex 17 days after shot still have shingles rash
Patient reported she has pain at site of Zostavax immunizations after 13 days from immunization. It is also itchy and tender.
she still feels a little droggy.; fever; chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 06Oct2021 12:45 (Lot number: FF8841) at the age of 76 years as 'dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1 : given on 09Feb2021, lot: EN53T8), administration date: 09Feb2021, when the patient was 75 years old, for COVID-19 immunization; Bnt162b2 (Dose 2 : given on 27Feb2021, lot: EN6202), administration date: 27Feb2021, when the patient was 75 years old, for COVID-19 immunization; Flu shot (Prior Vaccinations (within 4 weeks): She had flu shot last Monday. It was on either 27Sep2021 or 28Sep2021.), administration date: 27Sep2021. The following information was reported: PYREXIA (non-serious) with onset 07Oct2021 06:00, outcome "unknown", described as "fever"; CHILLS (non-serious) with onset 07Oct2021 06:00, outcome "unknown", described as "chills"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "she still feels a little droggy." Additional information:No Other Products were reported.AE(s) doesn't  require a visit to Emergency Room or Physician Office. Patient doesn't have any  AE(s) following prior vaccination. No Medical History was reported. Family Medical History Relevant to AE(s) was not Provided. No relevant test were reported. Patient asking is it safe to take Tylenol after receiving the Booster shot.  No follow-up attempts are possible. No further information is expected.
9cm red, swollen, and perfect circle site of where the flu shot was given. Site was also warm to touch.